Parkinson Disease and Complex Parkinsonism

Gene: NR4A2

Red List (low evidence)

NR4A2 (nuclear receptor subfamily 4 group A member 2)
EnsemblGeneIds (GRCh38): ENSG00000153234
EnsemblGeneIds (GRCh37): ENSG00000153234
OMIM: 601828, Gene2Phenotype
NR4A2 is in 7 panels

2 reviews

Arianna Tucci (Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square)

The gene product, Nurr1, was shown to be critical for dopaminergic cell development and survival, hence the gene has been sequenced in several candidate gene studies in PD. 12496759 identified two heterozygous mutations in 10/107 familial PD patients. Subsequent studies failed to identify pathogenic variants in PD (12827450, 15184637, 15276233). 15390059 identified a variant previously reported in Asian PD patients, in controls. So far, conflicting evidence regarding the role of NR4A2 In PD.
Created: 14 Dec 2016, 5:27 p.m.

Publications

Ellen McDonagh (Genomics England Curator)

Comment on list classification: Targeting Nurr-1 (NR4A2) as a therapy for PD targeted therapy is discuseed in PMID: 27012974; 25543265; 24126627. May be a susceptibility gene for PD - PMID: 22827504,19429166. Though variants reported in OMIM have been reclassified due to other studies not replicating an association, with more recent studies also finding no association (PMID: 19224617). Studies that do not find variants associated with Parkinson's disease in this gene - PMID:15197702, 15184637, 15390059, 15966003, 16977628 studies identifying potential susceptibility variants: 16532445.
Created: 3 Nov 2016, 2:04 p.m.

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Red
  • Illumina TruGenome Clinical Sequencing Services
Phenotypes
  • Parkinson Disease, Dominant/Recessive (susceptibility to)
OMIM
601828
Clinvar variants
Variants in NR4A2
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

19 Dec 2016, Gel status: 1

panel promoted to version 1

Ellen McDonagh (Genomics England Curator)

19th Dec 2016: panel revised according to expert review and further curation.

15 Dec 2016, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for NR4A2 were set to 12496759; 12827450; 15184637; 15276233; 15390059;27012974; 25543265; 24126627

15 Dec 2016, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for NR4A2 were set to 12496759; 12827450; 15184637; 15276233; 15390059

3 Nov 2016, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

3 Nov 2016, Gel status: 1

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for NR4A2 were set to Parkinson Disease, Dominant/Recessive (susceptibility to)

3 Nov 2016, Gel status: 1

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for NR4A2 were set to Parkinson Disease, Dominant/Recessive (susceptibility to).

3 Nov 2016, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

19 Oct 2016, Gel status: 1

Added New Source

Ellen McDonagh (Genomics England Curator)

NR4A2 was added to Parkinson Disease and Complex Parkinsonismpanel. Sources: Illumina TruGenome Clinical Sequencing Services

19 Oct 2016, Gel status: 0

Created

Ellen McDonagh (Genomics England Curator)

NR4A2 was created by ellenmcdonagh